Pacira Biosciences Inc PCRX:NASDAQ

Last Price$39.88NASDAQ Previous Close - Last Trade as of 3:59PM ET 7/19/19

Today's Change-0.58(1.43%)
Bid (Size)$39.87 (1)
Ask (Size)$39.88 (22)
Day Low / High$39.68 - 40.82
Volume340.3 K
 

View Pharmaceuticals: Other IndustryPeer Comparison as of 07/19/2019

 

Pacira Biosciences Inc ( NASDAQ )

Price: $39.88
Change: -0.58 (1.43%)
Volume: 340.3 K
3:59PM ET 7/19/2019
 
 

Prestige Consumer Healthcare Inc ( NYSE )

Price: $32.09
Change: 0.00 (0.00%)
Volume: 265.3 K
4:00PM ET 7/19/2019
 
 

Ironwood Pharmaceuticals Inc ( NASDAQ )

Price: $10.72
Change: 0.00 (0.00%)
Volume: 967.4 K
4:00PM ET 7/19/2019
 
 

Supernus Pharmaceuticals Inc ( NASDAQ )

Price: $32.03
Change: +0.01 (0.03%)
Volume: 311.7 K
3:59PM ET 7/19/2019
 
 

Portola Pharmaceuticals Inc ( NASDAQ )

Price: $26.64
Change: -0.24 (0.89%)
Volume: 750.4 K
4:00PM ET 7/19/2019
 

Read more news Recent News

Insider Trends: Insider Sale at Pacira Biosciences Reducing 90-Days of Buying
5:50PM ET 7/12/2019 MT Newswires

David M Stack, Director and CEO & Chairman, reported a sale of 13,115 shares in Pacira Biosciences (PCRX) for $562,377 on Jul 08, 2019. Following the Form...

2019, 2020 Earnings Estimates for Pacira Biosciences Scaled Up
1:26AM ET 7/10/2019 MT Newswires

The 2019 and 2020 full year forecasted earnings estimates for Pacira Biosciences Inc's (NASDAQ:PCRX, Recent Price: 43.42) have been scaled up. The...

Pacira Pharma Says Using Its Painkiller in Wisdom Tooth Extraction Cuts Later Opioid Use
11:52AM ET 6/26/2019 MT Newswires

Pacira Pharmaceuticals' (PCRX) said its Exparel anesthetic, when given to dental patients getting wisdom teeth removed, reduced the use of post-surgery...

Pacira Pharmaceuticals Says European Agency Accepts Marketing Application for Post-Surgical Painkiller
8:06AM ET 6/25/2019 MT Newswires

Pacira Pharmaceuticals (PCRX) said pre-market Tuesday that the European Medicines Agency has approved the company's Marketing Authorization Application for...

View all Commentary and Analysis

Biotech Stocks Getting Ready To Explode
11:38AM ET 6/17/2019 Seeking Alpha

BIIB Is For Buy-O-Gen
10:30AM ET 6/12/2019 Seeking Alpha

A Biotech-Friendly Event In An Unfriendly Healthcare Market
4:56PM ET 6/02/2019 Seeking Alpha

3 Gene Therapy Stocks For A Biotech Portfolio
12:53PM ET 5/20/2019 Seeking Alpha

Company Profile

Business DescriptionPacira Biosciences, Inc. operates as a holding company, which engages in the development, commercialization, and manufacture of pharmaceutical products for use in postsurgical outcomes for acute care practitioners and their patients. Its flagship product, EXPAREL, redefines pain management after surgery as an opioid-free alternative indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. The company was founded in December 2006 and is headquartered in Parsippany, NJ. View company web site for more details
Address5 Sylvan Way
Parsippany, New Jersey 07054
Phone+1.973.254.3560
Number of Employees518
Recent SEC Filing07/10/20194
Chairman, Chief Executive & Operating OfficerDavid M. Stack
PresidentMax Reinhardt
Chief Financial OfficerCharles A. Reinhart
Vice President-Research & DevelopmentVladimir Kharitonov

Company Highlights

Price Open$40.35
Previous Close$40.46
52 Week Range$35.07 - 55.00
Market Capitalization$1.6 B
Shares Outstanding41.3 M
SectorHealth Technology
IndustryPharmaceuticals: Other
Next Earnings Announcement08/01/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings238.00
Earnings per Share$0.20
Beta vs. S&P 500N/A
Revenue$337.3 M
Net Profit Margin2.10%
Return on Equity2.40%

Analyst Ratings as of 07/12/2019

Buy
8
Overweight
0
Hold
7
Underweight
0
Sell
1
Consensus RecommendationConsensus Icon
Powered by Factset